Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 4:00 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | OAK HILL ADVISORS LP | 3,613,338 6.390% | 3,613,338 (New Position) | View |
| 2024-11-08 5:23 pm Sale | 13G | Emergent BioSolutions Inc. EBS | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,224,727 4.200% | -649,257 (-22.59%) | View |
| 2024-09-10 12:09 pm Sale | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 1,968,784 3.700% | -1,870,591 (-48.72%) | View |
| 2024-07-08 4:32 pm Sale | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 3,839,375 7.300% | -2,799,039 (-42.16%) | View |
| 2024-06-07 1:30 pm Sale | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 6,638,414 12.700% | -2,760,783 (-29.37%) | View |
| 2024-02-13 5:04 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 2,974,638 5.730% | 328,272 (+12.40%) | View |
| 2024-02-09 6:19 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,873,984 5.540% | 2,873,984 (New Position) | View |
| 2024-01-23 10:52 am Sale | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 1,062,951 2.050% | -69,004 (-6.10%) | View |
| 2024-01-19 2:40 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 9,399,197 18.100% | 17,305 (+0.18%) | View |
| 2024-01-18 4:16 pm Sale | 13G | Emergent BioSolutions Inc. EBS | MILLENNIUM MANAGEMENT LLC | 2,095,662 4.000% | -615,737 (-22.71%) | View |
| 2023-11-07 3:33 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 9,381,892 18.100% | 2,981,689 (+46.59%) | View |
| 2023-10-10 11:27 am Sale | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 1,131,955 2.180% | -4,686,000 (-80.54%) | View |
| 2023-10-10 11:07 am Sale | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 2,646,366 5.110% | -2,759,908 (-51.05%) | View |
| 2023-09-07 4:18 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | MILLENNIUM MANAGEMENT LLC | 2,711,399 5.200% | 2,711,399 (New Position) | View |
| 2023-09-07 09:38 am Sale | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 6,400,203 12.400% | -2,555,015 (-28.53%) | View |
| 2023-02-09 11:19 am Purchase | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 5,406,274 10.840% | 53,322 (+1.00%) | View |
| 2023-01-26 08:43 am Unchanged | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,955,218 18.000% | 0 (Unchanged) | View |
| 2023-01-20 3:00 pm Purchase | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 8,955,218 18.000% | 878,317 (+10.87%) | View |
| 2023-01-10 08:13 am Purchase | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 5,817,955 11.660% | 2,785,228 (+91.84%) | View |
| 2022-03-09 08:44 am Sale | 13G | Emergent BioSolutions Inc. EBS | VANGUARD GROUP INC | 5,352,952 10.600% | -9,079 (-0.17%) | View |